Corporate / M&A

At Kennedy Van der Laan, Fenna van Dijk assists healthcare clients with corporate matters, and IP specialist Maarten Schut advises on a range of issues in the life sciences arena including R&D collaborations, licensing work and the protection of trade secrets. The team also acts for its healthcare clients on mergers, the establishment of joint ventures, medical liability cases, disciplinary actions and data protection mandates.

Experienced team advising on a range of corporate matters, including joint ventures, acquisitions and governance issues. Additionally assists with contracting matters. Further experience acting for start-ups on the establishment of their businesses. Predominantly represents healthcare providers.

Clients observe that the team is "very knowledgeable and practical."Additionally clients highlight that the group is "result and client-oriented."

Fenna van Dijk frequently acts for healthcare providers on a range of corporate matters, including acquisitions, joint ventures and governance structures. Additionally assists clients with market entries, contractual and compliance matters.

Kennedy Van der Laan has a special focus on mergers and joint ventures together with medical liability and disciplinary actions. The team is a member of Biolegis, the pan-European network of independent law firms with a focus on life sciences. Fenna van Dijk heads the healthcare team and Maarten Schut specialises in IP within the life sciences sector. Meltem Koning advises on corporate and private equity matters. The group advised the Oncode Institute, a new ‘super’ institute combining oncology research from numerous academic hospitals and research institutes. It assisted with its set up and governance, funding negotiations, and complex IP arrangements. In other work includes advising on licensing, R&D collaborations, and patent disputes.